Basic Information
| LncRNA/CircRNA Name | NONHSAT113026 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | renal cell carcinoma |
| ICD-0-3 | C64.9 |
| Methods | qPCR |
| Sample | RCC tissues,cell lines(786-O,ACHN) |
| Expression Pattern | up-regulated |
| Function Description | NOAT113026 was overexpressed in 786-O and ACHN cell lines by lentivirus-mediated technology and the oncological behavioral changes of RCC cells were observed along with tumorigenicity in experimental nude mice. |
| Pubmed ID | 31545257 |
| Year | 2019 |
| Title | LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-?B/p50 and SLUG. |
External Links
| Links for NONHSAT113026 | GenBank HGNC NONCODE |
| Links for renal cell carcinoma | OMIM COSMIC |